KANEKA CORPORATION
4118・Prime Market・Chemicals
KANEKA CORPORATION4118
KANEKA CORPORATION4118
Reference Indicators
Market Cap
3,569¥100M
P/E (Forecast)
10.8x
P/B
0.7x
Dividend Yield (Forecast)
3.71%
ROE
6.4%
EV/EBITDA
6.4x
Financial Summary
Unit: ¥M
| Item | 2022Mar 2022 | 2023Mar 2023 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|
Net Sales | 691,530 | 755,821 | 762,302 | 807,200 | 811,638 |
Cost of Sales | 494,880 | 556,895 | 558,087 | 581,555 | 586,088 |
Gross Profit | 196,649 | 198,926 | 204,214 | 225,644 | 225,550 |
SG&A Expenses | 153,086 | 163,838 | 171,635 | 185,594 | 192,655 |
Operating Income | 43,562 | 35,087 | 32,579 | 40,050 | 32,894 |
Non-operating Income | 3,681 | 4,951 | 5,713 | 3,528 | 5,026 |
Non-operating Expenses | 6,427 | 7,627 | 9,069 | 10,715 | 9,048 |
Ordinary Income | 40,816 | 32,411 | 29,222 | 32,863 | 28,873 |
Extraordinary Income | 1,671 | 1,410 | 7,586 | 13,289 | 25,536 |
Extraordinary Losses | 6,082 | 1,448 | — | 9,382 | 9,649 |
Pre-tax Income | 36,405 | 32,373 | 36,808 | 36,770 | 44,760 |
Income Taxes | 8,676 | 8,298 | 12,033 | 9,965 | 12,179 |
Net Income | 26,487 | 23,008 | 23,220 | 25,309 | 30,977 |
EBITDA | 82,072 | 75,193 | 74,033 | 84,710 | 80,825 |
Gross Margin | 28.4% | 26.3% | 26.8% | 28.0% | 27.8% |
Operating Margin | 6.3% | 4.6% | 4.3% | 5.0% | 4.1% |
ROA | 3.6% | 2.9% | 2.7% | 2.8% | 3.2% |
ROE | 7.1% | 5.7% | 5.3% | 5.5% | 6.4% |
Segment Performance
Unit: ¥M
2026
| Segment | Net Sales | Operating Income | Operating Margin |
|---|---|---|---|
| Material Solutions Unit | 327,235 | 24,928 | 7.6% |
| Quality of Life Solutions Unit | 194,340 | 17,954 | 9.2% |
| Health Care Solutions Unit | 82,975 | 14,840 | 17.9% |
| Nutrition Solutions Unit | 205,977 | 13,712 | 6.7% |
| その他 | 1,109 | 551 | 49.7% |